Fabian Hink
fabian-hink.bsky.social
Fabian Hink
@fabian-hink.bsky.social
Current mission: Reducing undruggability | protein-protein interactions, RNA-protein interactions, IDPs | Tools: mRNA display for cyclic peptide discovery & protein design | Postdoc | Copenhagen- & plant-based 🌱
Reposted by Fabian Hink
And the legacy continues! 😊

@amjjbonvin.bsky.social @bioinfo.se @lindorfflarsen.bsky.social #EMBOIntegMod25 ! 🍀🧿
October 6, 2025 at 1:13 PM
Reposted by Fabian Hink
We are hiring at the Department of Drug Design and Pharmacology.
Check out these opportunities and consider becoming our new colleague at University of Copenhagen.

employment.ku.dk/faculty/?sho...
164291 Associate Professor or Professor
employment.ku.dk
July 8, 2025 at 12:52 PM
Reposted by Fabian Hink
Learn about #AI tools in #protein #science, including design and engineering, at the EMBO Practical Course "AI for protein design" in Puerto Varas, Chile, 3–9 November 2025.

Deadline: 1 August

meetings.embo.org/event/25-ai-...
#LifeSciences #research #training #ProteinStructure #EMBOevents 🧪
AI for protein design
In the last 5 years, the scientific community has witnessed the development of several AI-based tools for groundbreaking advances in protein science. These tools have enabled scientists to predict pr…
meetings.embo.org
July 7, 2025 at 12:07 PM
Reposted by Fabian Hink
hanging out with strangers in a campus pub should be considered part of the serious process of thinking
June 26, 2025 at 12:14 PM
Reposted by Fabian Hink
New preprint: Allostery is a widespread cause of loss-of-function variant pathogenicity by the great
@xt117.bsky.social
biorxiv.org/content/10.1...
Allostery is a widespread cause of loss-of-function variant pathogenicity
Allosteric communication between non-contacting sites in proteins plays a fundamental role in biological regulation and drug action. While allosteric gain-of-function variants are known drivers of onc...
biorxiv.org
June 25, 2025 at 6:11 PM
Reposted by Fabian Hink
Tougher peptides, smarter targets 🔒🧬

Cyclic β-amino acid–based helical peptide library leads to stable, cell-permeable SARS-CoV-2 Mpro inhibitors! New #RSCChemBio #advancearticle shows off RaPID selection power 💥

doi.org/10.1039/D5CB...
RaPID discovery of cell-permeable helical peptide inhibitors con-taining cyclic β-amino acids against SARS-CoV-2 main protease
Structurally constrained cyclic β-amino acids are attractive building blocks for peptide drugs because they induce unique and stable conformations. Introduction of (1S,2S)-2-aminocyclopentanecarboxylic acid [(1S,2S)-2-ACPC] into peptides stabilizes helical conformations, so improving proteolytic stability and cell
doi.org
June 24, 2025 at 2:32 PM
Reposted by Fabian Hink
This is wild!
Engineering E. coli bacteria to turn plastic waste into paracetamol (Tylenol)
www.nature.com/articles/s41...
www.nature.com/articles/s41...
June 23, 2025 at 6:55 PM
Reposted by Fabian Hink
In the nucleus, many intrinsically disordered proteins (IDPs) form condensates. What IDP sequence features drive this behavior? We developed CondenSeq, a high-throughput approach to measure nuclear condensate formation, and applied it to ~14,000 IDPs to find out!

rdcu.be/eq975
Characterizing protein sequence determinants of nuclear condensates by high-throughput pooled imaging with CondenSeq
Nature Methods - CondenSeq is an imaging-based, high-throughput platform for characterizing condensate formation within the nuclear environment, uncovering the protein sequence features that...
rdcu.be
June 17, 2025 at 3:26 AM
Reposted by Fabian Hink
The remarkable benefit of exercise was just extended to improved survival after cancer in a randomized trial
@nejm.org
nejm.org/doi/full/10....
June 1, 2025 at 2:52 PM
Reposted by Fabian Hink
Very pleased to share the 'last' first-author paper from my postdoc with Prof. Christian Heinis at EPFL.
Now out in its final form in @angewandtechemie.bsky.social as a 'Very Important Paper' 🔥 (1/🧵) #chemsky
onlinelibrary.wiley.com/doi/10.1002/...
Bulk Measurement of Membrane Permeability for Random Cyclic Peptides in Living Cells to Guide Drug Development
Some cyclic peptides can cross membranes, which is highly attractive for drug development, but it remains difficult to accurately predict membrane permeability or to test it experimentally for large ...
onlinelibrary.wiley.com
June 2, 2025 at 10:01 AM
Reposted by Fabian Hink
Inside a Scientific Paper Mill

@dereklowe.bsky.social writes about how Csaba Szabo was contacted by a paper mill and offered money if he could help them write more junk papers.

www.science.org/content/blog...
Inside a Scientific Paper Mill
www.science.org
May 23, 2025 at 4:24 PM
Reposted by Fabian Hink
🚨We have an opening for a postdoc to use protein design techniques to developing and characterizing binders against intrinsically disordered proteins involved in neuroscience.

Experience in protein biochemistry and/or molecular neuroscience preferred.

Share: 🙏

mbg.au.dk/aktuelt/ledi...
Postdoc: De novo protein design for neuroscience - Ledig stilling på Aarhus Universitet
Ledig stilling ved Institut for Molekylærbiologi og Genetik - Neurobiologi, Aarhus Universitet
mbg.au.dk
May 21, 2025 at 12:04 PM
Reposted by Fabian Hink
Hiro's paper is out! @hiro-cg5445.bsky.social
Collaboration and Tour de Force with Richard Wheeler @zephyris-science.bsky.social and many other coauthors.
Big congratulations and thank you to anyone involved!

www.nature.com/articles/s41...
Small-molecule dissolution of stress granules by redox modulation benefits ALS models - Nature Chemical Biology
Uechi et al. found that a small-molecule lipoamide dissolves stress granules (SGs) by targeting SFPQ, a redox-sensitive disordered SG protein, alleviating pathological phenotypes caused by amyotrophic...
www.nature.com
May 14, 2025 at 2:44 PM
Reposted by Fabian Hink
Qiyao Zhu from the Biomolecular Design team at the #FlatironCCB has a new paper out on tools for modeling long, heterochiral, cyclic peptides: dx.plos.org/10.1371/jour...

Applications coming soon!
@flatironinstitute.org
Heuristic energy-based cyclic peptide design
Author summary Cyclic peptides are circular chains of amino acid residues that are promising candidates for new therapeutic drugs. Current FDA approved cyclic peptide-based drugs are mostly derived fr...
dx.plos.org
May 5, 2025 at 9:00 PM
Reposted by Fabian Hink
If u ever had to depict proteins as schematics in papers, u know the dilemma: how to create a pretty “blob”?
If structure ends up big & central, u’ll render it with PyMol et al, but for a truly schematic depiction u want a biorender-style icon, but for YOUR protein.
Think I’ve finally found a way.
May 3, 2025 at 12:40 PM
Reposted by Fabian Hink
Come and join us! We’re hiring a new Group Leader in Generative Biology at the @sangerinstitute.bsky.social

Building AI models or the data to train them?

Core funding of >$130M a year for a faculty of ~30.

www.nature.com/naturecareer...

acrobat.adobe.com/id/urn:aaid:...

pls RT!
May 6, 2025 at 2:59 PM
Reposted by Fabian Hink
In this evaluation of AlphaFold3 (and other methods), we show that (i) accurate predictions are limited to RNA structures/complexes with structural similarity to PDB and (ii) that current methods are bad at estimating the accuracy of the predictions. www.biorxiv.org/content/10.1...
Limits of deep-learning-based RNA prediction methods
Motivation: In recent years, tremendous advances have been made in predicting protein structures and protein-protein interactions. However, progress in predicting the structure of RNA, either alone or...
www.biorxiv.org
May 5, 2025 at 1:01 PM
Reposted by Fabian Hink
Excited to see this out in @science.org today!! www.science.org/doi/10.1126/...
May 1, 2025 at 6:17 PM
Reposted by Fabian Hink
Excited to share Benson’s and Maria’s work in collab w/Kostas Tzelepis: we found the nucleolar protein NPM1 is a marker of AML and can be targeted therapeutically

connecting ‘cell surface RNA biology’ to cancer biology

@natbiotech.nature.com
www.nature.com/articles/s41...
April 23, 2025 at 11:44 AM
Reposted by Fabian Hink
SCAM ALERT. This is a fake conference that ripped off my and other people’s names to trick people into registering. There is no such conference that I or the others shown were invited or agreed to. We are working to try to get this fraud taken down from the web.

chemsymposia.com
Join Chemsymposia 2026: Research & Innovation | ChemSymposia 2026
Join us at Chemsymposia 2026 to discover groundbreaking research in physics applications. Connect with experts, engage in insightful discussions, and explore our venue, registration details, and speak...
chemsymposia.com
April 11, 2025 at 4:35 PM
Reposted by Fabian Hink
🎉 Big news! Our paper is out in Nature Machine Intelligence!
"InstaNovo enables diffusion-powered de novo peptide sequencing in large-scale proteomics experiments"
🔗 www.nature.com/articles/s42...
👇 Thread 🧵
InstaNovo enables diffusion-powered de novo peptide sequencing in large-scale proteomics experiments - Nature Machine Intelligence
InstaNovo, a transformer-based model, and InstaNovo+, a multinomial diffusion model, enhance de novo peptide sequencing, enabling discovery of novel peptides, improved therapeutics sequencing coverage...
www.nature.com
April 1, 2025 at 7:30 AM
Reposted by Fabian Hink
Fast & Fair peer review: a pilot study demonstrating feasibility of rapid, high-quality peer review in a biology journal
Traditional peer review is slow, often delayed by the time-consuming process of identifying reviewers and lengthy review turnaround times. This study tests the feasibility of the Fast & Fair peer review initiative by evaluating whether we could implement and adhere to a structured timeline for rapid peer review at Biology Open. A 6-month pilot conducted from July to December 2024 evaluated a structured workflow with pre-contracted reviewers under two payment models: a freelance model or a retainer model. All manuscripts assigned to two of the journal's ten academic editors were included in the Fast & Fair peer review initiative experiment. A structured editorial timeline ensured that all manuscripts received reviews and first decisions within 7 business days. The results demonstrated that 100% of Fast & Fair peer review initiative manuscripts met the turnaround target, with a mean of 4.6 business days (n=20 manuscripts). Review quality was maintained, as indicated by assessments by academic editors. The freelancer model outperformed retainers in cost-effectiveness. These findings suggest that the Fast & Fair peer review initiative is feasible and does not compromise review quality. While scalability remains to be tested, the initiative eliminates a major bottleneck in traditional peer review by streamlining reviewer identification and enforcing a strict editorial timeline. ### Competing Interest Statement The authors of this manuscript have the following competing interests: D.A.G. is the Editor-in-Chief of Biology Open and A.C. is the Managing Editor of Biology Open.
www.biorxiv.org
March 29, 2025 at 7:42 AM
Reposted by Fabian Hink
Small proteins can be more complex than they look!

We know proteins fluctuate between different conformations- but by how much? How does it vary from protein to protein? Can highly stable domains have low stability segments? @ajrferrari.bsky.social experimentally tested >5,000 domains to find out!
March 26, 2025 at 4:21 PM